The cholesterol controversy is over. Why did it take so long?-Reference-Cited by-同舟云学术

The cholesterol controversy is over. Why did it take so long?

Published:1989-10 Issue:4 Volume:80 Page:1070-1078
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Steinberg D¹

Affiliation:

1. Department of Medicine, University of California, San Diego, La Jolla 92093-0613.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.80.4.1070

Reference45 articles.

1. Lowering Blood Cholesterol to Prevent Heart Disease

2. Strategies for the prevention of coronary heart disease;European Atherosclerosis Society Study Group;Eur Heart J,1987

3. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults;Expert Panel;Arch Intern Med,1988

4. The Lipid Research Clinics Coronary Primary Prevention Trial Results

5. Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genuine versus bogus scientific controversies: the case of statins;History and Philosophy of the Life Sciences;2021-10-14

2. Cholesterol: the race to the bottom;European Heart Journal;2021-08-02

3. A RETROSPECTIVE COHORT STUDY TO UNDERSTAND THE AGE, GENDER AND RISK FACTORS PATTERN IN PATIENTS ATTENDING FOR CARDIAC REHABILITATION (CR) AFTER CORONARY ARTERY BYPASS GRAFTING (CABG) SURGERY;INDIAN JOURNAL OF APPLIED RESEARCH;2021-07-01

4. Consensus statement from 2nd International Conference on Controversies in Vitamin D;Reviews in Endocrine and Metabolic Disorders;2020-03

5. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at “Extreme” ASCVD Risk;Current Diabetes Reports;2019-11-21